Neuroplastic Pain: The Science and How to Reverse It

21 min read

Quick Answer

Neuroplastic pain is chronic pain generated by learned neural pathways in the brain rather than ongoing tissue damage. The International Association for the Study of Pain recognized this mechanism in 2017. A randomized trial in JAMA Psychiatry (Ashar et al., 2022, n=151) found 66% of chronic pain patients became pain-free with Pain Reprocessing Therapy, confirmed at five-year follow-up.

TU
Tauri Urbanik · Pain Science Researcher

What Is Neuroplastic Pain?

Neuroplastic pain is chronic pain generated by learned neural pathways in the brain rather than ongoing tissue damage. Think of it as an alarm system that got stuck in the on position. The pain is completely real. The source just isn't where you feel it.

If a doctor ever told you 'nothing is wrong' or hinted that it was psychological, that hurt. And it was also wrong.

Neuroplastic pain is not imaginary. It shows up on brain scans. The anterior insula. The anterior midcingulate cortex. The periaqueductal gray. Those structures light up the same way they do when there's an active injury. Your nervous system is running a real protection program. The program just got stuck.

Notice the word 'real' showing up again and again. That's not an accident. Chronic pain patients, especially women, have spent years being told their pain was exaggerated, psychological, or imagined. Coady and colleagues (2024) found that medical invalidation is so common in chronic pain care that shame statistically mediates the link between being dismissed and developing depression. So let's be clear. Nothing in this page is saying your pain is in your head the way 'in your head' gets used to wave people away. Your pain is biology. The biology just happens to involve learning, prediction, and the brain.

The International Association for the Study of Pain formally recognized this mechanism in 2017, calling it nociplastic pain. ASRA Pain Medicine published the first major clinical guide using 'neuroplastic pain' as the primary term in February 2026. And the landmark randomized trial at the University of Colorado Boulder, published in JAMA Psychiatry (Ashar et al., 2022, n=151), showed 66% of chronic pain patients became pain-free in four weeks by targeting these learned neural pathways directly.

Tor Wager, one of the senior researchers on that trial, put it this way. If the causes of pain are in the brain, the solutions are there too.

And the part that changes everything: if your brain learned this pain, it can unlearn it. Neuroplastic pain is reversible. That's not marketing language. That's what the five-year follow-up data showed.

The Proof That Your Brain Creates Pain on Its Own

Start with a case the British Medical Journal published in 1995 that still stops people cold.

A construction worker jumped off some scaffolding onto a six-inch nail. The nail went straight through his boot. He was in writhing, screaming agony. The ER team gave him fentanyl before they even tried to remove it.

When they cut the boot away, the nail had passed cleanly between his toes. His foot was completely uninjured. Not a scratch.

So where did all that pain come from?

His brain ran the numbers before the boot came off. Nail. Boot. Force. Construction site. It calculated: catastrophic injury. And it delivered exactly the pain you'd expect from a nail through your foot. Maximum danger assessment, maximum pain output. The brain didn't wait for a damage report. It made a prediction.

Now consider phantom limb pain. Up to 80% of amputees feel pain in a limb that's no longer there. No tissue. No peripheral nerve. The brain creates it entirely. And the pain is so real that people describe burning, crushing, squeezing sensations in toes that have been gone for decades.

V.S. Ramachandran showed that a five-dollar mirror could eliminate years of phantom pain by giving the brain new visual information. In a New England Journal of Medicine trial, Chan and colleagues (2007) found mirror therapy reduced pain in 100% of the mirror group, while 50% of controls got worse. MacIver and colleagues (Brain, 2008) showed that mental imagery alone reversed the cortical reorganization driving the pain. The brain physically changed back.

Then there's the Anzio beachhead, 1944. Harvard anesthesiologist Henry Beecher documented 215 soldiers with severe combat wounds. Compound fractures. Penetrating chest wounds. Three out of four refused morphine. Their wounds were survivable, which meant they were going home alive. Same tissue damage, completely different pain, because the meaning had changed.

The IASP updated its official definition of pain in 2020 to reflect all of this. The updated note reads, in effect, that pain and nociception are different phenomena. Nociception is neither necessary nor sufficient for pain. That's the governing body of the field stating plainly that you can have pain without tissue damage, and tissue damage without pain.

Pain is what the brain decides pain is.

And that has enormous implications. Because if your brain decides, your brain can change its decision. That's the door neuroplastic pain opens.

66% pain-free in 4 weeks

The largest controlled trial targeting neuroplastic pain produced results that held at five-year follow-up

Ashar et al., JAMA Psychiatry, 2022 (n=151 RCT, University of Colorado Boulder)

Pain Reprocessing Therapy taught patients to reinterpret their pain as brain-generated rather than structural. A mediation analysis (Ashar et al., JAMA Network Open, 2023) confirmed reattribution was the key mechanism. Before PRT, only 10% of patients' pain attributions were mind or brain related. After PRT, 51% were.

How Pain Gets Stuck: The Neuroscience

Your brain has a pain system. It's supposed to protect you. Touch a hot stove, it fires. Sprain an ankle, it keeps you off it. That's useful pain.

But the system can get stuck.

In 1983, Clifford Woolf published a paper in Nature that changed the field. He showed that after an injury, the central nervous system itself becomes hypersensitive. Pain signals get amplified. Things that shouldn't hurt start hurting. And here's the critical part: blocking the original injury did not reverse the changes. The nervous system had changed on its own.

He called it central sensitization. It's the single most important concept in modern pain science.

Think of it like a burglar alarm. Normally it goes off when there's an intruder. But this alarm got so sensitive it triggers when a leaf blows past the window. The alarm is real. It's just wrong.

Woolf and Tim Salter expanded the idea in a landmark 2000 Science paper titled 'Neuronal plasticity: increasing the gain in pain.' The nervous system turns up the volume on pain signals and forgets to turn it down. Volume knob stuck at eleven.

In 2003, Ru-Rong Ji, Woolf, and their colleagues published a paper in Trends in Neurosciences with a quietly radical finding. Pain and memory share the same cellular mechanisms. The same long-term potentiation processes that let you remember a phone number allow your nervous system to learn pain. This isn't a metaphor. It's neurobiology. And it's the reason pain can be unlearned.

Then came the brain imaging studies that showed who actually gets stuck.

A. Vania Apkarian's team at Northwestern published a series of studies in Nature Neuroscience. They tracked patients with acute back pain and watched their brains over time. The stunning finding, published by Marwan Baliki and colleagues in 2012: corticostriatal connectivity predicted the transition from acute to chronic pain with over 80% accuracy. Let that sink in. Not the severity of the injury. Not the imaging findings. The connectivity pattern in the brain decided who would still hurt a year later.

In 2013, Javeria Hashmi, again with Apkarian's group, published in Brain that chronic back pain physically migrates inside the brain. It starts in sensory circuits. As it becomes chronic, it shifts into emotional circuits. The pain literally changes neighborhoods.

All of this points to a deeper framework from theoretical neuroscience. Karl Friston's free energy principle, applied to pain by Ongaro and Kaptchuk (PAIN, 2019), reframes your brain as a prediction machine. Pain isn't a readout of tissue damage. It's the brain's best guess about danger. Ongaro and Kaptchuk put it starkly. We feel pain because we predict that we are in pain.

Expectations shape the signal all the way down. In a Science review, Katja Wiech (2016) showed that expectations modulate pain from spinal cord to cortex. A single striking study found that positive expectations doubled the effect of remifentanil, one of the most powerful opioids available. Negative expectations completely eliminated it. The brain overrode the drug.

And the learning goes further. Once the nervous system is sensitized, it starts pairing pain with context. The desk where you sit during the day. The car where you commute. The bedroom where you lie awake waiting for it to start. Vlaeyen and Linton's fear-avoidance model (PAIN, 2000, cited over 5,000 times) describes how these contextual pairings solidify through classical conditioning. The chair doesn't cause tissue damage. But your nervous system has learned that the chair means pain is coming, and the prediction itself generates the signal. This is why pain so often feels like it has a mind of its own. In a sense, it does.

This is why your pain is worse on stressful days. Why it fades on vacation. Why it flares when you sit at your desk but not when you're hiking. Your body didn't change between Tuesday and Saturday. Your brain's prediction did.

Why Your MRI Findings Don't Explain Your Pain

Your doctor saw something on your MRI. A disc bulge. A meniscal tear. A rotator cuff fray. That finding is real. You're not imagining it.

But here's what you probably weren't told.

Walter Brinjikji and colleagues at the Mayo Clinic (AJNR, 2015) pooled 33 imaging studies covering 3,110 people with zero back pain. Not mild back pain. No pain at all. They found disc degeneration in 37% of pain-free 20-year-olds, climbing to 96% of 80-year-olds. Disc bulges in 30% of pain-free 20-year-olds, reaching 84% at age 80.

So if your MRI shows disc degeneration and you're 60, so does the MRI of almost everyone your age who has no back pain at all.

The pattern repeats across every major joint. Research suggests asymptomatic structural findings are the rule, not the exception, across the body.

Rotator cuff tears: 65% asymptomatic in the general population (Minagawa et al., 2013, n=664). Meniscal tears: 61% asymptomatic in Englund and colleagues' New England Journal of Medicine study (2008, n=991). Labral tears in the hip: 69% asymptomatic (Register et al., 2012). Cervical disc bulges: 87.6% asymptomatic in Nakashima's Spine study of 1,211 people (2015). Knee osteoarthritis on X-ray: only 47% of people with radiographic OA report any pain at all (Hannan et al., 2000, n=6,880).

Then there are the sham surgery trials, which close the loop.

Bruce Moseley's NEJM trial (2002) compared arthroscopic knee surgery to a sham procedure where surgeons made incisions but did nothing inside the joint. Results at two years: identical. The CSAW trial (Beard et al., The Lancet, 2018) showed the same for shoulder decompression surgery. FIMPACT (Paavola et al., BMJ, 2018) confirmed it for rotator cuff. Three major trials, three negative results, three conditions where structural surgery did no better than a carefully staged fake.

None of this means your doctor is wrong. Your findings are real. They're just extremely common in people who feel fine. And that means the findings alone can't explain why you hurt.

This is actually the best possible news. If structural damage were driving your pain, you'd be stuck with it. But it isn't. The pain is coming from your nervous system's interpretation of signals, not from mechanical breakdown. And interpretations can change. That's what reversible means in practical terms.

The many names for the same phenomenon

Neuroplastic pain

Created byAlan Gordon (The Way Out, 2021)
Best forPatients, apps, media
StatusWidely used, informal

Nociplastic pain

Created byIASP (Kosek et al., 2016-2017)
Best forResearchers, clinicians
StatusOfficial IASP classification

Central sensitization

Created byClifford Woolf (1983)
Best forPhysiotherapists, educators
StatusMechanism descriptor

Tension myositis syndrome (TMS)

Created byDr. John Sarno (1984)
Best forSarno community
StatusNot accepted mainstream

Psychophysiologic disorders (PPD)

Created bySchubiner, Gordon, Schechter, Clarke (2010)
Best forClinicians in Sarno tradition
StatusNiche clinical

How Do You Know If Your Pain Is Neuroplastic?

Quick note on the terminology above. Central sensitization is a mechanism. Nociplastic pain is a clinical category. Neuroplastic pain is the patient-facing term. They're not quite synonyms. Nijs, Malfliet, and Nishigami (Brazilian Journal of Physical Therapy, 2023) have written carefully about the distinction. The mechanism describes what's happening in your spinal cord and brain. The clinical terms describe the category of pain those mechanisms produce. For everything below, we're using neuroplastic pain because that's what most people search for.

Now to the question you actually came here for. How do you know if YOUR pain fits this pattern?

Howard Schubiner, a clinical professor at Michigan State and one of the physicians bridging the Sarno tradition with modern research, developed a simple framework. He calls it F.I.T.

F is for Functional. Your pain doesn't follow a clean anatomical pattern. It spreads. It moves. It doesn't match the expected map for the finding on your imaging. You've tried multiple structural treatments (physical therapy, injections, splints, maybe surgery) and none of them delivered lasting relief.

I is for Inconsistent. Your pain varies with stress, emotions, and context. Good days and bad days for no physical reason. Worse at night when your mind won't quiet down. Better on vacation. Flares before a difficult phone call. Sometimes it moves around, showing up in a different body part than yesterday. Sometimes every test comes back normal.

T is for Triggered. Your pain started during a stressful life period rather than after a clear injury. Or there was an injury, but the normal healing window (three to six months) closed a long time ago and the pain stayed.

Think about your own pain for a second. Does it follow a predictable body-based pattern? Or does it shift with your mood, your situation, your day of the week?

Structural damage doesn't care whether it's Tuesday or Saturday. It doesn't know you have a deadline. It doesn't ease up when you're laughing with friends.

If your pain does any of that, something other than structure is driving it. In a 2024 analysis, Schubiner estimated that 88.3% of chronic back and neck pain meets criteria for primary (neuroplastic) pain. This isn't the exception. It's the rule. And that means the category you're probably in is also the one with the most promising treatment evidence. The science is catching up to what your nervous system has been telling you all along.

Do these patterns sound familiar?

Check any that apply to you.

Try This Now

Rate your pain right now, 0 to 10. Now think about the most stressful thing in your life. A deadline. A relationship. A money worry. Something that tightens your chest just to consider it. Hold that thought for 10 seconds. Rate your pain again. If it moved even half a point, you just demonstrated the neuroplastic pain mechanism in real time. Structural damage doesn't respond to a thought. Your nervous system does. Now try the reverse. Think about somewhere you felt completely safe. A beach you love. A childhood memory. A moment with someone who looked at you like you mattered. Hold it for 10 seconds. If your pain dropped, even slightly, that's your nervous system responding to safety. That's the exact mechanism Pain Reprocessing Therapy, somatic tracking, and EAET use to retrain your pain system. You just did it yourself, from a cold start, in under a minute.

Why Understanding Neuroplastic Pain Isn't Enough

What you just did in sixty seconds is the mechanism. The same one tested in the Boulder trial. The same one the five-year follow-up confirmed. Your nervous system responded to safety cues, and your pain signal moved.

But here's what that sixty seconds can't do. It can't rewire nine years of learned pain in one sitting.

In the Boulder trial, the patients who became pain-free didn't just learn about neuroplastic pain. They practiced reattribution for ten minutes a day, four weeks straight, with a trained therapist guiding them through the hard parts. The Lumley and Yarns EAET trials followed the same structure. Sessions plus daily homework. Guided, personalized, repeated until the nervous system actually updated its predictions.

You can read every book on neuroplastic pain. You can understand the science perfectly. You can explain central sensitization to your friends at dinner. And Monday morning, when your back locks up at 6 AM, understanding won't be enough. Knowing what somatic tracking is and doing somatic tracking when you're scared and hurting are two completely different skills. One is reading. The other is practice.

That's the piece that gets lost between the research and the kitchen table. The science is clear about what works. It's also clear that it takes daily repetition, applied to your specific pain, with guidance when you get stuck. A single exercise on a webpage can show you the door. Walking through it takes practice.

Your pain responded to a thought. Find out if it's neuroplastic.

A 3-minute assessment maps your pain patterns against the research. It tells you whether what you just experienced points to a neuroplastic mechanism, and what the evidence says about your specific condition.

Start the Free Assessment

Free. 3 minutes. No account needed.

Which Conditions Are Neuroplastic?

Neuroplastic pain isn't one condition. It's a mechanism that shows up across dozens of diagnoses. When researchers target the nervous system instead of the body part, patients improve regardless of what's written on the chart.

Here's the rough map, condition by condition.

Chronic back pain. The strongest data by a wide margin. 66% became pain-free with PRT in the Boulder trial (Ashar et al., JAMA Psychiatry, 2022). Maher and colleagues (The Lancet, 2017) estimate 85% of chronic back pain has no identifiable structural cause. The match between what the spine looks like and what the patient feels is weaker than almost any other field of medicine.

Fibromyalgia. EAET outperformed CBT by nearly 3x in Mark Lumley's 2017 PAIN trial (n=230), and by nearly 4x in Brian Yarns's 2024 JAMA Network Open trial of older veterans (63% vs 17%). A 2025 genome-wide association study of 2.5 million people found fibromyalgia heritability enriched exclusively in brain tissues. Fibromyalgia is genetically real AND brain-based. Both things can be true.

TMJ. The 2023 BMJ network meta-analysis by Yao and colleagues pooled 153 randomized trials and 8,713 patients across 59 interventions. The strong recommendation was for CBT plus biofeedback. The strong recommendations against were for surgery and irreversible dental interventions.

IBS. A 2025 meta-analysis found all 12 included trials reported gut-directed hypnotherapy superior to control. Effect size 0.73. 'You can eat normally again' isn't a marketing claim. It's a reproducible research finding.

Migraines. Central sensitization is documented in 60 to 90% of chronic migraine patients. Biofeedback carries Grade A evidence from the American Academy of Neurology.

Sciatica. 56% of patients in Peul and colleagues' Dutch NEJM trial (2007) recovered fully without surgery. Your disc bulge was almost certainly there before the pain started.

Knee pain. 61% of meniscal tears in the general population are asymptomatic. Moseley's sham surgery trial remains one of the most disorienting findings in orthopedics.

Shoulder pain. 65% of all rotator cuff tears cause zero pain. Two sham surgery trials (CSAW and FIMPACT) showed decompression works no better than a carefully staged fake procedure.

Neck pain. The 2025 JAMA trial by Jo Nijs and colleagues showed pain neuroscience education reduced neck disability by 33% versus 16% for usual care, holding at 12 months. Disability cut in half, from education alone.

Hip pain. 69% of pain-free hips have labral tears on MRI (Register et al., 2012). Direct treatment trials for hip specifically are still emerging, but the mechanism fits the same pattern.

The mechanism also reaches beyond pain. Tinnitus may involve the same predictive processing errors (Mohan et al., 2024). PPPD, a chronic dizziness condition, shows the same central sensitization signature. These aren't random findings. They're what happens when a single learning system gets stuck across different sensory domains. The name on the chart matters less than what's driving the signal underneath it. And the thing driving the signal can change.

If you saw your condition on that list and something clicked, a 3-minute assessment can tell you whether your specific pain pattern fits the neuroplastic profile. It's free, no account needed.

How Neuroplastic Pain Is Treated

If your pain fits the neuroplastic pattern, the next question is practical. What do you actually do about it?

Four approaches carry serious clinical data behind them. They're not competing schools. They're different angles on the same underlying mechanism: updating your brain's threat assessment.

[Pain Reprocessing Therapy](/pain-reprocessing-therapy). Developed by Alan Gordon and tested in the Boulder trial. PRT teaches you to reinterpret pain sensations through a lens of safety rather than danger. The core move: observing the sensation with curiosity instead of fear while reminding your nervous system that nothing is broken. The Boulder trial showed 66% became pain-free in four weeks, with durable effects at five-year follow-up.

Emotional Awareness and Expression Therapy (EAET). Developed by Mark Lumley and Howard Schubiner. EAET targets the emotional drivers that keep the nervous system in threat mode. In the Yarns 2024 trial (JAMA Network Open), EAET produced 63% clinically significant pain reduction in older veterans versus 17% for CBT. The experiential approach beat the cognitive one by nearly 4 to 1.

Somatic tracking. The practical technique at the heart of PRT. You turn your attention toward the pain sensation, observe it without resistance, and let your brain gather new information about what the signal actually means. Simple to describe. Takes patience to learn. A book can explain somatic tracking clearly enough that you understand it. But understanding it and practicing it at 6 AM when your back is screaming are different things. Reading about swimming and swimming are different things. The skill lives in the doing.

Pain Neuroscience Education. Adriaan Louw's 2016 meta-analysis confirmed what sounded too good to be true. Teaching people how pain works reduces pain, fear, disability, and catastrophizing. Louw's point: education IS treatment. Reading this page is itself a mild therapeutic intervention. But for most people, it's the starting dose, not the full course.

All four share one assumption. Chronic pain is a learning problem, not a tissue problem. The nervous system learned to generate a signal. The nervous system can learn to stop.

If you've read Dr. John Sarno and you're exploring the modern science, the complete TMS guide traces how his 1984 insight became the research base we have today.

Now for the part most articles leave out. In the Boulder trial, PRT wasn't a book. It was nine sessions with a trained therapist plus daily homework between them. In the Lumley and Yarns EAET trials, the same structure. Sessions, and between-session practice. Understanding alone didn't rewire anyone. The knowledge was necessary. It just wasn't sufficient. What moved the numbers was guided, daily practice applied to the patient's specific pain.

And that's the gap most people fall into. You finish a book on neuroplastic pain convinced. Monday morning comes, the pain is still there, and you're alone in the kitchen with no idea what to actually do about it. The understanding was real. The daily practice piece was missing.

That gap is what PainApp was built for. The AI Pain Coach uses the same reattribution mechanism Ashar and Gordon tested in the Boulder trial, applied in the moment to whatever you're feeling that morning. The condition-specific courses turn somatic tracking into a guided ten-minute routine for your specific condition, not a general concept you remember from chapter six. The F.I.T. Pain Tracker runs Schubiner's clinical framework in the background, so you can watch the pattern he describes show up across your own week. None of this replaces reading Alan Gordon or seeing a PRT-certified therapist if you can find one. It's the daily rehearsal that, in every trial cited on this page, was what actually worked. Before changing anything about your current treatment, talk to your healthcare provider first.

Mark41 · chronic back pain · 9 years

Mark had seen four doctors, done PT, tried injections, and was on a surgical wait list. For nine years his L4-L5 disc bulge was 'the problem.' Then his wife noticed something. In Costa Rica his back stopped hurting by day three and flared the day before their flight home. Spine didn't change between Saturday and Sunday. His brain's threat assessment did.

Mark read The Way Out that month. He understood the science. He believed it. And for three months after finishing the book, nothing changed. He knew his pain was neuroplastic. He just didn't know what to do with that knowledge at 6 AM when his back locked up.

He started PainApp's back pain course that April. Ten minutes every morning, walking him through somatic tracking for his specific back pattern, with the AI Pain Coach answering whatever came up. The difference wasn't the information. He already had that. The difference was doing it daily, guided, specific to what he was feeling that particular morning. Within six weeks his pain dropped from 7 to 2. He lifted his six-year-old onto his shoulders for the first time in years. Still gets twinges on stressful Mondays. But he knows what they mean now, and they pass.

Composite story based on common patient experiences. Not a specific individual.

The Science Behind Neuroplastic Pain

Here's what the research trajectory looks like in one paragraph. In 2017, the International Association for the Study of Pain adopted nociplastic pain as a third category alongside nociceptive and neuropathic. In 2022, the University of Colorado Boulder published the landmark Pain Reprocessing Therapy trial in JAMA Psychiatry, showing 66% of chronic back pain patients became pain-free in four weeks, with results holding at five-year follow-up (Ashar et al., 2022, n=151). In 2024, Kaplan and colleagues published a comprehensive review in Nature Reviews Neurology establishing nociplastic pain as a distinct clinical category. In 2025, a 2.5 million-person genome-wide association study found fibromyalgia heritability enriched exclusively in brain tissues, and Jo Nijs's JAMA trial cut neck disability in half at 12 months using pain neuroscience education alone. In February 2026, ASRA Pain Medicine published the first major clinical guide using 'neuroplastic pain' as its primary term.

Nine years from contested theory to clinical guideline. That's fast.

The mechanism research is just as striking. Seifert and Maihofner (2011) showed that the physical brain changes caused by chronic pain are reversible. Gray matter volume, cortical thickness, white matter integrity. All of it can return toward normal when treatment works. Buchel and colleagues (Neuron, 2014) reframed the entire ascending and descending pain system as a single hierarchical predictive coding network. Top-down signals carry predictions about danger. Bottom-up signals carry the errors when reality doesn't match. Chronic pain may be what happens when the prediction machinery gets stuck favoring the pain hypothesis, treating any variation as confirmation instead of correction.

The prevalence numbers are striking too. Howard Schubiner's 2024 analysis found 88.3% of chronic back and neck pain met criteria for primary (neuroplastic) pain. Nociplastic pain affects an estimated 5 to 15% of the general population. Among fibromyalgia patients, 44 to 57% have comorbid overlapping pain conditions. That clustering makes sense if they share a single central mechanism.

Sleep and stress amplify the whole system. Krause and colleagues (Journal of Neuroscience, 2019) found that a single night of sleep deprivation increased somatosensory cortex activity by 120% while decreasing the brain's pain-dampening systems by 60 to 90%. That's why your pain is worse the morning after a bad night. It's not your imagination. It's measurable shifts in brain circuitry.

That's the research foundation PainApp was built on. The AI Pain Coach applies the reattribution mechanism from the Boulder trial. The condition-specific courses deliver Louw's pain neuroscience education protocol. The F.I.T. Pain Tracker runs Schubiner's clinical framework as a daily tool. Same evidence base as the JAMA Psychiatry trial, in a form you can practice every morning before work.

Rule out the small percentage of serious causes with your healthcare provider first. Then, if your pain fits the nociplastic profile, the approach with the strongest evidence base in the entire field of chronic pain is also the one that feels the most optimistic. Your pain is real. Your body is sound. Your brain is generating signals that can be updated. The science took nine years to arrive. You don't have to wait that long.

Ready to start retraining your nervous system?

Day 1, you take a 3-minute assessment. Day 2, your first 10-minute somatic tracking session, guided for your specific condition. By day 7, you've done the same daily practice the Boulder trial participants did. Same mechanism, same duration, personalized to your pain pattern and coached by AI trained on the research you just read.

Start 7 days free

7 days free. Cancel anytime.

TU
Tauri Urbanik

Pain Science Researcher

Researching neuroplastic pain science and recovery methods for 3+ years.

Published Apr 10, 2026Next review Jun 9, 2026

Frequently Asked Questions

Neuroplastic pain is chronic pain generated by learned neural pathways in the brain rather than ongoing tissue damage. The International Association for the Study of Pain formally recognized this mechanism in 2017, calling it nociplastic pain. A 2022 JAMA Psychiatry trial by Ashar and colleagues showed 66% of chronic pain patients became pain-free using Pain Reprocessing Therapy, with results holding at five-year follow-up.

Yes. It's physically measurable on brain scans and classified by the IASP as the third category of pain alongside nociceptive (tissue-based) and neuropathic (nerve-based) pain. The brain generates real pain signals through learned neural pathways, even when no tissue damage is present. Phantom limb pain is the clearest proof: up to 80% of amputees feel genuine pain in a limb that no longer exists.

Central sensitization, where the nervous system becomes hypersensitive and amplifies pain signals (Clifford Woolf, Nature, 1983). Brain connectivity patterns, not injury severity, predict who develops chronic pain (Baliki et al., Nature Neuroscience, 2012). Stress, fear, past trauma, and sleep disruption all contribute to maintaining the sensitized state.

Pain Reprocessing Therapy produced a 66% pain-free rate in a 2022 JAMA Psychiatry trial (Ashar et al., 2022). Other validated approaches include Emotional Awareness and Expression Therapy (63% response vs 17% for CBT in Yarns et al., JAMA Network Open, 2024), pain neuroscience education, and somatic tracking. These target the brain's threat-detection system rather than body tissues.

Howard Schubiner's F.I.T. criteria offer a starting framework. Functional: pain doesn't follow clean anatomy. Inconsistent: varies with stress, mood, and context. Triggered: started during stress or persists past normal healing timelines of 3 to 6 months. Schubiner's 2024 analysis found 88.3% of chronic back and neck pain meets these criteria. A healthcare provider can rule out structural causes first.

Many chronic pain conditions involve neuroplastic mechanisms, including chronic back pain, fibromyalgia, TMJ, IBS, migraines, sciatica, and chronic knee, shoulder, neck, hip, and pelvic pain. The IASP formally classifies fibromyalgia, chronic primary back pain, and other conditions as nociplastic pain. The mechanism may also extend to tinnitus and chronic dizziness.

They describe the same phenomenon. 'Nociplastic pain' is the official IASP clinical term, adopted in 2017 by Kosek and colleagues. 'Neuroplastic pain' is the patient-facing term popularized by Alan Gordon in his 2021 book The Way Out. Both refer to pain arising from altered central nervous system processing without evidence of tissue damage.

Research says yes. Pain uses the same neural learning mechanisms as memory (Ji et al., Trends in Neurosciences, 2003). The Boulder study showed 66% of chronic back pain patients became pain-free in 4 weeks, with results holding at five-year follow-up (Ashar et al., JAMA Psychiatry, 2022). Brain imaging confirmed physical reversal of pain-related brain changes.

Central sensitization is a mechanism. It describes how the central nervous system amplifies pain signals (Clifford Woolf, 1983). Neuroplastic pain is a clinical category of chronic pain arising from that mechanism and other neuroplastic changes. They're closely related but not quite synonyms (Nijs, Malfliet, Nishigami, Brazilian Journal of Physical Therapy, 2023).

Some people do recover after reading about neuroplastic pain and applying the concepts independently. But the clinical trials that produced the strongest results all used structured daily practice with professional guidance. The Boulder trial (Ashar et al., JAMA Psychiatry, 2022) involved nine therapist-led sessions plus daily homework over four weeks. The EAET trials followed the same pattern. Understanding the science is a real therapeutic step, but the research consistently shows that guided, daily practice produces better outcomes than self-directed reading alone.

In the Boulder trial, 66% of chronic back pain patients became pain-free after four weeks of daily Pain Reprocessing Therapy practice (Ashar et al., JAMA Psychiatry, 2022). The EAET trials by Lumley and Yarns showed clinically significant improvement over 8 to 12 weeks. Individual timelines vary based on pain duration, the specific condition, and consistency of daily practice. The five-year follow-up of the Boulder trial confirmed that results held long-term for most participants.

References

  1. Ashar YK, Gordon A, Schubiner H, et al. Effect of Pain Reprocessing Therapy vs Placebo and Usual Care for Patients With Chronic Back Pain: A Randomized Clinical Trial. JAMA Psychiatry. 2022;79(1):13-23. PubMed
  2. Ashar YK, Gordon A, Schubiner H, et al. Reattribution to Mind-Brain Processes as a Key Mechanism of Pain Reprocessing Therapy. JAMA Network Open. 2023;6(1):e2252353. PubMed
  3. Woolf CJ. Evidence for a central component of post-injury pain hypersensitivity. Nature. 1983;306(5944):686-688. DOI
  4. Woolf CJ, Salter MW. Neuronal plasticity: increasing the gain in pain. Science. 2000;288(5472):1765-1769. DOI
  5. Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends in Neurosciences. 2003;26(12):696-705. DOI
  6. Baliki MN, Petre B, Torbey S, et al. Corticostriatal functional connectivity predicts transition to chronic back pain. Nature Neuroscience. 2012;15(8):1117-1119. DOI
  7. Hashmi JA, Baliki MN, Huang L, et al. Shape shifting pain: chronification of back pain shifts brain representation from nociceptive to emotional circuits. Brain. 2013;136(9):2751-2768. DOI
  8. Brinjikji W, Luetmer PH, Comstock B, et al. Systematic Literature Review of Imaging Features of Spinal Degeneration in Asymptomatic Populations. AJNR Am J Neuroradiol. 2015;36(4):811-816. PubMed
  9. Louw A, Zimney K, Puentedura EJ, Diener I. The efficacy of pain neuroscience education on musculoskeletal pain: A systematic review of the literature. Physiotherapy Theory and Practice. 2016;32(5):332-355. PubMed
  10. Lumley MA, Schubiner H, Lockhart NA, et al. Emotional Awareness and Expression Therapy, Cognitive Behavioral Therapy, and Education for Fibromyalgia: A Cluster-Randomized Controlled Trial. PAIN. 2017;158(12):2354-2363. PubMed
  11. Yarns BC, Lumley MA, Cassidy JT, et al. Emotional Awareness and Expression Therapy vs Cognitive Behavioral Therapy for Chronic Pain in Older Veterans. JAMA Network Open. 2024;7(4):e245216. PubMed
  12. Kosek E, Cohen M, Baron R, et al. Do we need a third mechanistic descriptor for chronic pain states? Pain. 2016;157(7):1382-1386. DOI
  13. Kosek E, Clauw D, Nijs J, et al. Chronic nociplastic pain affecting the musculoskeletal system: clinical criteria and grading system. Pain. 2021;162(11):2629-2634. DOI
  14. Fitzcharles MA, Cohen SP, Clauw DJ, Littlejohn G, Usui C, Hauser W. Nociplastic pain: towards an understanding of prevalent pain conditions. The Lancet. 2021;397(10289):2098-2110. DOI
  15. Kaplan CM, Kelleher E, Irani A, et al. Deciphering nociplastic pain: clinical features, risk factors and potential mechanisms. Nature Reviews Neurology. 2024;20(6):347-363. DOI
  16. Chan BL, Witt R, Charrow AP, et al. Mirror therapy for phantom limb pain. New England Journal of Medicine. 2007;357(21):2206-2207. DOI
  17. Moseley JB, O'Malley K, Petersen NJ, et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. New England Journal of Medicine. 2002;347(2):81-88. DOI
  18. Fisher JP, Hassan DT, O'Connor N. Minerva. British Medical Journal. 1995;310(6971):70. DOI
  19. Wiech K. Deconstructing the sensation of pain: The influence of cognitive processes on pain perception. Science. 2016;354(6312):584-587. DOI
  20. Vlaeyen JW, Linton SJ. Fear-avoidance and its consequences in chronic musculoskeletal pain: a state of the art. Pain. 2000;85(3):317-332. DOI
  21. Nijs J, Malfliet A, Nishigami T. Nociplastic pain and central sensitization in patients with chronic pain conditions: a terminology update for clinicians. Brazilian Journal of Physical Therapy. 2023;27(3):100518. DOI
  22. Beard DJ, Rees JL, Cook JA, et al. Arthroscopic subacromial decompression for subacromial shoulder pain (CSAW): a multicentre, pragmatic, parallel group, placebo-controlled, three-group, randomised surgical trial. The Lancet. 2018;391(10118):329-338. DOI
  23. Beecher HK. Pain in men wounded in battle. Annals of Surgery. 1946;123(1):96-105.
  24. Nijs J, Malfliet A, Ickmans K, et al. Pain neuroscience education for chronic neck pain: A randomized clinical trial. JAMA. 2025.
  25. Ongaro G, Kaptchuk TJ. Symptom perception, placebo effects, and the Bayesian brain. PAIN. 2019;160(1):1-4. DOI
  26. Maher C, Underwood M, Buchbinder R. Non-specific low back pain. The Lancet. 2017;389(10070):736-747. DOI
  27. Englund M, Guermazi A, Gale D, et al. Incidental meniscal findings on knee MRI in middle-aged and elderly persons. New England Journal of Medicine. 2008;359(11):1108-1115. PubMed
  28. Minagawa H, Yamamoto N, Abe H, et al. Prevalence of symptomatic and asymptomatic rotator cuff tears in the general population: From mass-screening in one village. Journal of Orthopaedics. 2013;10(1):8-12. DOI
  29. Peul WC, van Houwelingen HC, van den Hout WB, et al. Surgery versus prolonged conservative treatment for sciatica. New England Journal of Medicine. 2007;356(22):2245-2256. DOI
  30. Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ. 2023;383:e076766. DOI
  31. Register B, Pennock AT, Ho CP, et al. Prevalence of abnormal hip findings in asymptomatic participants: a prospective, blinded study. American Journal of Sports Medicine. 2012;40(12):2720-2724. PubMed
  32. Nakashima H, Yukawa Y, Suda K, Yamagata M, Ueta T, Kato F. Abnormal findings on magnetic resonance images of the cervical spines in 1211 asymptomatic subjects. Spine. 2015;40(6):392-398. DOI
  33. Paavola M, Malmivaara A, Taimela S, et al. Subacromial decompression versus diagnostic arthroscopy for shoulder impingement: randomised, placebo surgery controlled clinical trial. BMJ. 2018;362:k2860. DOI
  34. Coady D, Godard A, Holtzman S. The role of pain-related shame in the relationship between medical invalidation and depressive symptoms in chronic pain. Journal of Pain. 2024. DOI
  35. Seifert F, Maihofner C. Functional and structural imaging of pain-induced neuroplasticity. Current Opinion in Anaesthesiology. 2011;24(5):515-523. DOI
  36. Buchel C, Geuter S, Sprenger C, Eippert F. Placebo analgesia: a predictive coding perspective. Neuron. 2014;81(6):1223-1239. DOI
  37. Krause AJ, Prather AA, Wager TD, Lindquist MA, Walker MP. The Pain of Sleep Loss: A Brain Characterization in Humans. Journal of Neuroscience. 2019;39(12):2291-2300. DOI

Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider about your specific condition. Pain is real regardless of its source. Neuroplastic pain is a legitimate medical phenomenon, not a suggestion that pain is imaginary. If you are in crisis, contact FindAHelpline.com for immediate support.